The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relative thrombocytosis following chemoradiation of patients with glioblastoma to predict survival.
 
Keeratikarn Boonyawan
No Relationships to Disclose
 
Jie Yang
No Relationships to Disclose
 
Lihong Long
No Relationships to Disclose
 
Qianghu Wang
No Relationships to Disclose
 
Ravesanker Ezhilarasan
No Relationships to Disclose
 
Audia Alessandra
No Relationships to Disclose
 
Kenneth R. Hess
Travel, Accommodations, Expenses - Angiochem
 
Kristin Alfaro
No Relationships to Disclose
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celldex; Deciphera; Foundation Medicine; Genentech/Roche; Vascular Biogenics
Speakers' Bureau - Celldex; Deciphera; Omniox; Oxigene
Research Funding - Deciphera; EMD Serono; Lilly; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
 
Krishna Bhat
No Relationships to Disclose
 
Erik P. Sulman
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Abbvie (Inst); Novocure (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme